Company Filing History:
Years Active: 2020-2022
Title: The Innovations of Carlos Martinez Fleites
Introduction
Carlos Martinez Fleites is an accomplished inventor based in Stevenage, GB. He has made significant contributions to the field of biotechnology, particularly in the area of targeted protein degradation. With a total of 2 patents to his name, Fleites is recognized for his innovative approaches to controlling polypeptide sequences.
Latest Patents
Fleites' latest patents focus on a method of controlling the level of a polypeptide sequence. This involves administering a polypeptide sequence fused to a ubiquitin targeting protein that comprises a minimal degron structural motif. Notably, the polypeptide sequence includes a chimeric antigen receptor, making this invention particularly useful in cell and gene therapy where the activity of the chimeric antigen receptor needs to be regulated.
Career Highlights
Carlos Martinez Fleites is currently associated with GlaxoSmithKline Intellectual Property Development Limited. His work at this prominent company allows him to further his research and development efforts in innovative biotechnological solutions.
Collaborations
Fleites has collaborated with notable colleagues such as Lewis Lee Brayshaw and Michael Menteith Hann. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.
Conclusion
Carlos Martinez Fleites is a notable inventor whose work in targeted protein degradation has the potential to impact the fields of cell and gene therapy significantly. His contributions to biotechnology continue to pave the way for innovative solutions in medical science.